Video

Dr Soumya Vishwanath on Knowledge Gaps Regarding Digital Therapeutics for Behavioral Health Disorders

Author(s):

Soumya Vishwanath, PharmD, senior manager of formulary management at Magellan Rx Management, explained what she wishes more people understood about digital therapeutics for behavioral health disorders.

Soumya Vishwanath, PharmD, senior manager of formulary management at Magellan Rx Management, explained what she wishes more people understood about digital therapeutics for behavioral health disorders at the Academy of Managed Care Pharmacy's annual meeting.

Transcript

What’s the number 1 thing that you want payers to understand about digital therapeutic tools for behavioral health disorders?

Great question. I would say the number 1 thing is to recognize that this is a very evolving space. There's lots of learning and relearning that's occurring based on the regulatory process of how these therapies are approved, how we want to evaluate these therapies, what's the ideal patient population. So, really just taking this in and organizing how to objectively review the criteria and the product would be the number 1 thing that I would recommend.

Related Videos
Monica Kraft, MD, ATSF.
Michael Arzt, MD.
Ravin Ratan, MD, MEd, MD Anderson
Dr Ajay Goel
Julie Linton, MD, FAAP.
Jan Hedner, MD, PhD.
Dr Migvis Monduy
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
Amy Shapiro, MD
Adam Benjafield, PhD.
Related Content
CH LogoCenter for Biosimilars Logo